Calyxt Stock Price, News & Analysis (NASDAQ:CLXT)

$20.50 0.65 (3.27 %)
(As of 12/11/2017 01:37 PM ET)
Previous Close$19.85
Today's Range$19.50 - $20.89
52-Week Range$9.26 - $31.89
Volume57,300 shs
Average Volume79,834 shs
Market Capitalization$567.71 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A

About Calyxt (NASDAQ:CLXT)

Calyxt logoCalyxt, Inc. is a food and agriculture company. The Company is focused on delivering healthier specialty food ingredients, such as healthier oils and high fiber wheat, for consumers and agriculturally advantageous crop traits, such as herbicide tolerance to farmers. The Company also combines gene-editing technology and technical that enables to edit a plant genome to elicit the desired traits and characteristics. The Company products include Consumer Centric and Farmer Centric products. Consumer Centric product, which includes high oleic soybean, high fiber wheat, high fiber wheat II, reduced gluten wheat, cold storable potato and reduced browning potato. Farmer Centric products, which includes drought tolerant soybean, improved soybean, herbicide tolerant wheat, herbicide tolerant canola, herbicide tolerant alfalfa and herbicide quality alfalfa.The Company has several products under development including high oleic soybeans, powdery mildew resistant wheat and cold storable potato.

Receive CLXT News and Ratings via Email

Sign-up to receive the latest news and ratings for CLXT and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Agricultural Biotechnology
Sub-IndustryN/A
SectorConsumer Staples
SymbolNASDAQ:CLXT
CUSIPN/A
Phone651-683-2807

Debt

Debt-to-Equity Ratio0.13%
Current Ratio12.41%
Quick Ratio12.41%

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$390,000.00
Price / Sales1,455.50
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSN/A
Net Income$-12,080,000.00
Net Margins-5,969.52%
Return on Equity-101.69%
Return on Assets-76.32%

Miscellaneous

Employees27
Outstanding Shares27,690,000

Calyxt (NASDAQ:CLXT) Frequently Asked Questions

What is Calyxt's stock symbol?

Calyxt trades on the NASDAQ under the ticker symbol "CLXT."

Where is Calyxt's stock going? Where will Calyxt's stock price be in 2017?

4 brokerages have issued 1 year price targets for Calyxt's shares. Their forecasts range from $22.00 to $32.00. On average, they expect Calyxt's share price to reach $27.75 in the next year. View Analyst Ratings for Calyxt.

Who are some of Calyxt's key competitors?

Who are Calyxt's key executives?

Calyxt's management team includes the folowing people:

  • Andre Choulika, Chairman of the Board
  • Federico A. Tripodi, Chief Executive Officer
  • Bryan W. J. Corkal, Chief Financial Officer
  • Joseph B Saluri, General Counsel, Executive Vice President – Corporate Development
  • Daniel F. Voytas Ph.D., Chief Scientific Officer
  • Glenn R Bowers Ph.D., Vice President - Breeding
  • Michel Arbadji, Director of Business Development
  • Manoj Sahoo, Chief Commercial Officer
  • Laurent Arthaud, Director
  • Alain Godard, Director

When did Calyxt IPO?

(CLXT) raised $101 million in an IPO on Thursday, July 20th 2017. The company issued 6,100,000 shares at $15.00-$18.00 per share. Citigroup, Credit Suisse, JefferiesWells and Fargo Securities served as the underwriters for the IPO and BMO Capital Markets and Ladenburg Thalmann were co-managers.

When does Calyxt's lock-up period expire?

Calyxt's lock-up period expires on Tuesday, January 16th. Calyxt had issued 7,000,000 shares in its initial public offering on July 20th. The total size of the offering was $56,000,000 based on an initial share price of $8.00. Shares of the company owned by major shareholders and company insiders will be eligible for trade following the expiration of the lock-up period.

Who owns Calyxt stock?

Calyxt's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include Bank of New York Mellon Corp (0.08%), Schwab Charles Investment Management Inc. (0.05%), California State Teachers Retirement System (0.05%) and American International Group Inc. (0.02%). View Institutional Ownership Trends for Calyxt.

Who bought Calyxt stock? Who is buying Calyxt stock?

Calyxt's stock was bought by a variety of institutional investors in the last quarter, including Bank of New York Mellon Corp, Schwab Charles Investment Management Inc., California State Teachers Retirement System and American International Group Inc.. View Insider Buying and Selling for Calyxt.

How do I buy Calyxt stock?

Shares of Calyxt can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Calyxt's stock price today?

One share of Calyxt stock can currently be purchased for approximately $20.50.

How big of a company is Calyxt?

Calyxt has a market capitalization of $567.71 million and generates $390,000.00 in revenue each year. Calyxt employs 27 workers across the globe.

How can I contact Calyxt?

Calyxt's mailing address is 600 COUNTY ROAD D WEST SUITE 8, NEW BRIGHTON MN, 55112. The company can be reached via phone at 651-683-2807.


MarketBeat Community Rating for Calyxt (CLXT)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  60 (Vote Outperform)
Underperform Votes:  56 (Vote Underperform)
Total Votes:  116
MarketBeat's community ratings are surveys of what our community members think about Calyxt and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Calyxt (NASDAQ:CLXT) Analysts' Consensus Rating

  (How are Consensus Ratings Calculated?)
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyN/A
Consensus Rating Score: 2.752.753.00N/A
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $27.75$26.25$16.33N/A
Price Target Upside: 54.68% upside28.17% upside33.33% upsideN/A

Calyxt (NASDAQ:CLXT) Consensus Price Target History

Price Target History for Calyxt (NASDAQ:CLXT)

Calyxt (NASDAQ:CLXT) Analyst Ratings History

Show:
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
11/16/2017CitigroupLower Price TargetNeutral$27.00 -> $22.00N/AView Rating Details
11/1/2017Jefferies GroupBoost Price TargetBuy$27.00N/AView Rating Details
10/30/2017BMO Capital MarketsInitiated CoverageOutperform$32.00N/AView Rating Details
9/29/2017Wells Fargo & CompanyBoost Price TargetOutperform$17.00 -> $30.00MediumView Rating Details
(Data available from 12/11/2015 forward)

Earnings

Earnings History for Calyxt (NASDAQ:CLXT)


No earnings announcements for this company have been tracked by MarketBeat.com

Estimates

Calyxt (NASDAQ:CLXT) Earnings Estimates

2017 EPS Consensus Estimate: ($0.43)
2018 EPS Consensus Estimate: ($1.16)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q3 20171($0.20)($0.20)($0.20)
Q4 20171($0.23)($0.23)($0.23)
Q1 20181($0.26)($0.26)($0.26)
Q2 20181($0.27)($0.27)($0.27)
Q3 20181($0.32)($0.32)($0.32)
Q4 20181($0.31)($0.31)($0.31)
Q1 20191($0.27)($0.27)($0.27)
Q2 20191($0.28)($0.28)($0.28)
Q3 20191($0.30)($0.30)($0.30)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Calyxt (NASDAQ:CLXT)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Calyxt (NASDAQ CLXT) Insider Trading and Institutional Ownership History

Institutional Ownership Percentage: 21.13%
Insider Trades by Quarter for Calyxt (NASDAQ:CLXT)

Calyxt (NASDAQ CLXT) Insider Trades by Quarter

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/25/2017Philippe DumontDirectorBuy400$8.00$3,200.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Calyxt (NASDAQ CLXT) News Headlines

Source:
DateHeadline
Evogene (EVGN) and Calyxt (CLXT) Critical ContrastEvogene (EVGN) and Calyxt (CLXT) Critical Contrast
www.americanbankingnews.com - December 10 at 3:30 PM
Analyzing Evogene (EVGN) & Calyxt (CLXT)Analyzing Evogene (EVGN) & Calyxt (CLXT)
www.americanbankingnews.com - December 9 at 7:18 PM
Head to Head Analysis: Evogene (EVGN) vs. Calyxt (CLXT)Head to Head Analysis: Evogene (EVGN) vs. Calyxt (CLXT)
www.americanbankingnews.com - December 9 at 3:14 AM
Zacks: Calyxt, Inc. (CLXT) Receives Average Rating of "Buy" from AnalystsZacks: Calyxt, Inc. (CLXT) Receives Average Rating of "Buy" from Analysts
www.americanbankingnews.com - December 8 at 8:06 AM
Contrasting Calyxt (CLXT) and Evogene (EVGN)Contrasting Calyxt (CLXT) and Evogene (EVGN)
www.americanbankingnews.com - December 8 at 5:38 AM
Calyxt (CLXT) vs. Evogene (EVGN) Financial ContrastCalyxt (CLXT) vs. Evogene (EVGN) Financial Contrast
www.americanbankingnews.com - December 6 at 3:08 PM
Evogene (EVGN) vs. Calyxt (CLXT) Financial AnalysisEvogene (EVGN) vs. Calyxt (CLXT) Financial Analysis
www.americanbankingnews.com - December 4 at 7:39 PM
Evogene (EVGN) versus Calyxt (CLXT) Critical SurveyEvogene (EVGN) versus Calyxt (CLXT) Critical Survey
www.americanbankingnews.com - December 3 at 11:42 AM
Calyxt (CLXT) vs. Evogene (EVGN) Critical ComparisonCalyxt (CLXT) vs. Evogene (EVGN) Critical Comparison
www.americanbankingnews.com - December 3 at 11:42 AM
Head-To-Head Analysis: Evogene (EVGN) and Calyxt (CLXT)Head-To-Head Analysis: Evogene (EVGN) and Calyxt (CLXT)
www.americanbankingnews.com - December 2 at 1:08 PM
Financial Comparison: Calyxt (CLXT) vs. Evogene (EVGN)Financial Comparison: Calyxt (CLXT) vs. Evogene (EVGN)
www.americanbankingnews.com - December 2 at 1:06 PM
Head-To-Head Survey: Calyxt (CLXT) & Evogene (EVGN)Head-To-Head Survey: Calyxt (CLXT) & Evogene (EVGN)
www.americanbankingnews.com - November 30 at 9:58 PM
Financial Analysis: Evogene (EVGN) vs. Calyxt (CLXT)Financial Analysis: Evogene (EVGN) vs. Calyxt (CLXT)
www.americanbankingnews.com - November 30 at 11:18 AM
Calyxt (CLXT) Upgraded at Zacks Investment ResearchCalyxt (CLXT) Upgraded at Zacks Investment Research
www.americanbankingnews.com - November 28 at 7:50 PM
Critical Contrast: Evogene (EVGN) versus Calyxt (CLXT)Critical Contrast: Evogene (EVGN) versus Calyxt (CLXT)
www.americanbankingnews.com - November 27 at 5:28 AM
Financial Analysis: Evogene (EVGN) and Calyxt (CLXT)Financial Analysis: Evogene (EVGN) and Calyxt (CLXT)
www.americanbankingnews.com - November 26 at 4:14 AM
Reviewing Calyxt (CLXT) and Evogene (EVGN)Reviewing Calyxt (CLXT) and Evogene (EVGN)
www.americanbankingnews.com - November 25 at 8:14 AM
Critical Review: Evogene (EVGN) vs. Calyxt (CLXT)Critical Review: Evogene (EVGN) vs. Calyxt (CLXT)
www.americanbankingnews.com - November 25 at 5:12 AM
Critical Survey: Calyxt (CLXT) vs. Evogene (EVGN)Critical Survey: Calyxt (CLXT) vs. Evogene (EVGN)
www.americanbankingnews.com - November 24 at 8:24 AM
Financial Contrast: Evogene (EVGN) and Calyxt (CLXT)Financial Contrast: Evogene (EVGN) and Calyxt (CLXT)
www.americanbankingnews.com - November 24 at 8:16 AM
 Calyxt, Inc. (CLXT) Receives Average Recommendation of "Buy" from Analysts Calyxt, Inc. (CLXT) Receives Average Recommendation of "Buy" from Analysts
www.americanbankingnews.com - November 23 at 10:16 AM
Evogene (EVGN) versus Calyxt (CLXT) Head to Head ComparisonEvogene (EVGN) versus Calyxt (CLXT) Head to Head Comparison
www.americanbankingnews.com - November 21 at 7:33 PM
 Calyxt, Inc. (CLXT) Receives Average Rating of "Buy" from Brokerages Calyxt, Inc. (CLXT) Receives Average Rating of "Buy" from Brokerages
www.americanbankingnews.com - November 19 at 11:34 AM
Financial Contrast: Calyxt (CLXT) and Evogene (EVGN)Financial Contrast: Calyxt (CLXT) and Evogene (EVGN)
www.americanbankingnews.com - November 19 at 8:42 AM
Comparing Evogene (EVGN) and Calyxt (CLXT)Comparing Evogene (EVGN) and Calyxt (CLXT)
www.americanbankingnews.com - November 18 at 4:22 AM
FY2017 EPS Estimates for Calyxt, Inc. Cut by Jefferies Group (CLXT)FY2017 EPS Estimates for Calyxt, Inc. Cut by Jefferies Group (CLXT)
www.americanbankingnews.com - November 17 at 9:22 PM
Calyxt, Inc. (CLXT) PT Lowered to $22.00Calyxt, Inc. (CLXT) PT Lowered to $22.00
www.americanbankingnews.com - November 16 at 7:47 PM
Critical Contrast: Evogene (EVGN) and Calyxt (CLXT)Critical Contrast: Evogene (EVGN) and Calyxt (CLXT)
www.americanbankingnews.com - November 16 at 8:36 AM
Calyxt Reports Financial Results for Third Quarter and First Nine Months of 2017Calyxt Reports Financial Results for Third Quarter and First Nine Months of 2017
finance.yahoo.com - November 13 at 10:38 PM
Calyxt, Inc. breached its 50 day moving average in a Bearish Manner : CLXT-US : November 8, 2017Calyxt, Inc. breached its 50 day moving average in a Bearish Manner : CLXT-US : November 8, 2017
finance.yahoo.com - November 8 at 9:16 PM
Calyxt, Inc. (CLXT) Expected to Earn Q3 2017 Earnings of ($0.20) Per ShareCalyxt, Inc. (CLXT) Expected to Earn Q3 2017 Earnings of ($0.20) Per Share
www.americanbankingnews.com - November 6 at 1:22 AM
 Calyxt, Inc. (CLXT) Given Consensus Recommendation of "Buy" by Brokerages Calyxt, Inc. (CLXT) Given Consensus Recommendation of "Buy" by Brokerages
www.americanbankingnews.com - November 4 at 9:46 AM
CLXT Crosses Above Average Analyst TargetCLXT Crosses Above Average Analyst Target
www.thestreet.com - November 4 at 7:22 AM
Jefferies Group LLC Increases Calyxt, Inc. (CLXT) Price Target to $27.00Jefferies Group LLC Increases Calyxt, Inc. (CLXT) Price Target to $27.00
www.americanbankingnews.com - November 1 at 1:54 PM
Why Calyxt Stock Is Compelling At Current LevelsWhy Calyxt Stock Is Compelling At Current Levels
www.msn.com - October 30 at 4:03 PM
Zacks: Analysts Set $20.67 Price Target for Calyxt, Inc. (CLXT)Zacks: Analysts Set $20.67 Price Target for Calyxt, Inc. (CLXT)
www.americanbankingnews.com - October 20 at 2:46 AM
Zacks Investment Research Downgrades Calyxt, Inc. (CLXT) to SellZacks Investment Research Downgrades Calyxt, Inc. (CLXT) to Sell
www.americanbankingnews.com - October 16 at 8:10 PM
 Calyxt, Inc. (CLXT) Receives Average Recommendation of "Buy" from Brokerages Calyxt, Inc. (CLXT) Receives Average Recommendation of "Buy" from Brokerages
www.americanbankingnews.com - October 5 at 12:42 PM
Calyxt and S&W’s Gene-Edited Alfalfa Plant Designated as Non-Regulated by USDACalyxt and S&W’s Gene-Edited Alfalfa Plant Designated as Non-Regulated by USDA
finance.yahoo.com - October 2 at 5:35 PM
 Analysts Set $16.33 Target Price for Calyxt Inc. (CLXT) Analysts Set $16.33 Target Price for Calyxt Inc. (CLXT)
www.americanbankingnews.com - September 30 at 6:36 PM
Calyxt Inc. (CLXT) PT Raised to $30.00Calyxt Inc. (CLXT) PT Raised to $30.00
www.americanbankingnews.com - September 29 at 10:56 AM
UPDATE: Citi Downgrades Calyxt Inc. (CLXT) to Neutral - StreetInsider.comUPDATE: Citi Downgrades Calyxt Inc. (CLXT) to Neutral - StreetInsider.com
www.streetinsider.com - September 29 at 8:12 AM
Calyxt to Present at the Ladenburg Thalmann 2017 Healthcare ConferenceCalyxt to Present at the Ladenburg Thalmann 2017 Healthcare Conference
www.marketwatch.com - September 28 at 12:22 AM
Calyxt Inc. (CLXT) Lowered to Neutral at Citigroup Inc.Calyxt Inc. (CLXT) Lowered to Neutral at Citigroup Inc.
www.americanbankingnews.com - September 27 at 9:28 AM
Biotech firm Calyxt breaks ground on new headquartersBiotech firm Calyxt breaks ground on new headquarters
www.bizjournals.com - September 7 at 10:34 PM
Calyxt to Break Ground on New Concept-to-Fork Facility in Roseville, Minn.Calyxt to Break Ground on New Concept-to-Fork Facility in Roseville, Minn.
finance.yahoo.com - September 6 at 10:17 PM
Calyxt Incs (CLXT) Quiet Period Set To End  on August 29thCalyxt Inc's (CLXT) Quiet Period Set To End on August 29th
www.americanbankingnews.com - August 22 at 1:22 AM
Calyxt Inc (CLXT) Coverage Initiated at Citigroup Inc.Calyxt Inc (CLXT) Coverage Initiated at Citigroup Inc.
www.americanbankingnews.com - August 15 at 8:02 PM
Jefferies Group LLC Initiates Coverage on Calyxt Inc (NASDAQ:CLXT)Jefferies Group LLC Initiates Coverage on Calyxt Inc (NASDAQ:CLXT)
www.americanbankingnews.com - August 14 at 8:42 AM
Calyxt (CLXT) Announces July 20th IPOCalyxt (CLXT) Announces July 20th IPO
www.americanbankingnews.com - July 12 at 10:08 AM

SEC Filings

Calyxt (NASDAQ:CLXT) SEC Filings

DateFilerForm TypeView
12/01/2017
3:19 PM
Calyxt (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
View Filing

Social Media

Financials

Calyxt (NASDAQ:CLXT) Income Statement, Balance Sheet and Cash Flow Statement

Chart

Calyxt (NASDAQ CLXT) Stock Chart for Monday, December, 11, 2017

Loading chart…

This page was last updated on 12/11/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.